Immunization of travelers against japanese encephalitis Dr Catherine Goujon Centre médical de.

Slides:



Advertisements
Similar presentations
Meningococcemia: Epidemiology & Prevention Baylor College of Medicine Med-Peds Continuity Clinic Anoop Agrawal, M.D.
Advertisements

Hepatitis Prevention in Travellers Dr. Pierre J. Plourde Medical Officer of Health Medical Director, Travel Health and Tropical Medicine Winnipeg Regional.
A 23 year old business woman got two shots of hepatitis B 1 month apart 2 years ago. Today she is at your practice for ending the schedule. What should.
Hepatitis A and Hepatitis A Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control.
Travel Vaccination Dr. Samra A Yasin Petersfield Surgery 15 th September 2000.
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Judith Pinkham (Ph.D. Student) Walden University PUBH 8165 Instructor: Dr. Fredric Grant Summer 2013.
1 Japanese encephalitis Cause & prevention Department of Health Hong Kong SAR.
Travel Medicine Updates Rushabh Shah Regis University PharmD Candidate Class of /18/13.
Epidemiology and Prevention of Viral Hepatitis A to E: Hepatitis A Virus Division of Viral Hepatitis.
JCG CHINA 2014 Lead Practice Nurse Jacquie Coates Dr Chris Cook.
Viral Hepatitis - Historical Perspective A “Infectious” “Serum” Viral hepatitis Entericallytransmitted Parenterallytransmitted F, G, ? other E NANB BD.
Dr Hannah Kibuuka Makerere University Walter Reed Project Presentation at the Uganda Medical Association-Uganda Veterinary Association joint conference.
Instructions for users This slide presentation provides an overview of the epidemiology of JE. Below many of the slides, there are notes to explain the.
Effect of Vaccination to Control Japanese Encephalitis in Nepal: a review Dr. Ganesh Raj Pant Faculty of Animal Science, Veterinary Science and Fisheries,
NEPAL IS ALSO KNOWN AS. The country of Mount Everest.
JAPANESE ENCEPHALITIS
JAPANESE ENCEPHALITIS VIROLOGY PRESENTATION. GROUP MEMBERS: SYEDA KANWAL FATIMA NIMRAH GHOURI.
. A Randomized Clinical Trial of Immunization With Combined Hepatitis A and B Versus Hepatitis B Alone for Hepatitis B Seroprotection in Hemodialysis Patients.
Hepatitis A Issues and IAPCOI perspectives Dr Monjori Mitra Associate Professor Institute of Child Health Kolkata.
By Dr. Victoria J. Cabrera DVM.  Is a lethal encephalitis cause by a virus in the family Rhabdoviridae genus Lyssavirus  Exposure occurs through the.
CURRENT HEALTH PROBLEMS IN STUDENT'S HOME SOUNTRIES HEPATITIS B IN MALAYSIA MOHD ZHARIF ABD HAMID AMINUDDIN BAKI AMRAN.
Pertussis and Pertussis Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Local Updates in Vaccine- Preventable Diseases Anna Halloran Epidemiologist Spokane Regional Health District February 2016.
Hepatitis A Vaccination Offers Long-Term Immunity.
Impact of Childhood Hepatitis A Vaccination: New York City Vikki Papadouka, PhD, MPH Jane R. Zucker, MD, MSc Sharon Balter, MD Vasudha Reddy, MPH Kristen.
CONGENITAL RUBELLA SYNDROME Infectious and Tropical Pediatric Division Department of Child Health Medical Faculty, University of Sumatera Utara.
Guidelines for Vaccinating Dialysis Patients BY: DR. JONAIDI ASSOCIATE PROF. OF INFECTIOUS DISEASES.
Vaccines and Immunisations
Meningococcal Vaccination
And how the spread Diseases
Module 4 (e) Pregnancy and Breast Feeding
Epidemiology of Hepatitis A in Ireland Last updated March 2017
Presenter ITODO EWAOCHE
Safety and Immunogenicity Study of Rabies G Protein Vaccine Administered to Healthy Volunteers: A Preliminary Report RI Modi1, B Khamar1, D Sawhney1, M.
Family Rhabdoviridae. Rabies virus.
Human Papillomavirus Kenneth McCall, BSPharm, PharmD, BCGP
is caused by the Hepatitis A virus (HAV)
Royal Thai Army Roles of mosquito vectors, bats, and swine in the epidemiology of emerging and re-emerging infectious diseases Akina Sukasem, 2LT Kanokporn.
A Framework of ethical decision making
Malaria.
A Framework of ethical decision making
Epidemiology of Mumps Let’s move on now to mumps….
HPV VACCINES Dr. Kirtan Krishna.
Yellow fever deepak b. saxena.
CD-JEV Japanese Encephalitis Vaccine Introduction Training Modules for Health Care Workers Introduction to Japanese encephalitis and CD-JEV vaccine.
Influenza Vaccine Effectiveness Against Pediatric Deaths:
Yellow Fever Vaccination
Module 7 Communicating about CD-JEV vaccine with caregivers
Zika Virus in Pregnancy
Rebekah Doyle, Ph.D student
Controlling the risk of Chikungunya
Dr Paul T Francis, MD Community Medicine College of Medicine, Zawia
AAHA Pet Owner Guidelines
RISK R isk of Perinatal and Early Childhood Infection
What’s New in Adult Immunization
Epidemiological Modeling to Guide Efficacy Study Design Evaluating Vaccines to Prevent Emerging Diseases An Vandebosch, PhD Joint Statistical meetings,
JE vaccine eligibility
Annual UW Disaster Exercise
West Nile Virus & Eastern Equine Encephalitis
Preventing Meningococcal B Disease
The Hong Kong Medical Association Symposium on Influenza 2003
RUBELLA Dr.T.V.Rao MD.
Provincial Measles Immunization Catch-Up Program
A large proportion of immigrant youth are susceptible to chickenpox (varicella). Evidence indicates that up to 50% of youth at age 15 who are immigrants.
Epidemiology of hepatitis A in Ireland
The impact of one dose Hepatitis A vaccine in Latin America
The Local and Global Impact of HIV
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Rabies: FAQs. o The rabies virus is very sensitive to heat. Cooking dog meat will kill the virus o If eaten, the rabies virus is also killed by the acids.
Presentation transcript:

Immunization of travelers against japanese encephalitis Dr Catherine Goujon Centre médical de l’Institut Pasteur

Immunization of travelers against japanese encephalitis

Immunization of travelers against japanese encephalitis 1. The disease Arthropod borne virus genus Flavivirus transmitted by mosquito of Culex species with nocturnal activity. Transmission occurs in rural areas with rice cultivation and flood irrigation. Anthropozoonosis

Immunization of travelers against japanese encephalitis 2. Epidemiology The most common cause of viral encephalitis in Asia* Incidence : 68 000 cases/year, i.e. 8,2 /100 000 13 600 à 20 400 deceases per year Predominance : children < 15 years old. *WHO Fact sheet No 386 December 2015

Immunization of travelers against japanese encephalitis 2. Epidemiology* Seasonal transmission in temperate areas : peaks in summer and fall ; Seasonal transmission in sub tropical areas, varies with monsoon rain and irrigation practices ; Year-round transmission in tropical areas. *http://invs.santepubliquefrance.fr//international/notes/encephalite_japonaise_asie_se_160807.pdf.

Immunization of travelers against japanese encephalitis 3. Clinical features Frequently asymptomatic ; Severe encephalopathy : 1 case / 250 ; case-fatality rate : 40% à 60% ; permanent neurologic and psychiatric sequelae : 1 case /3 ; No specific treatment. 4. Prevention Protection against mosquito bites ; Vaccination.

Immunization of travelers against japanese encephalitis 5. Estimated risk of infection for a non immunised traveler Very low : from 1/20 000 to 1/5000 per week of stay, (79 cases notified from 1973 to 2015 among non immunized travelers or expatriates - CDC Yellow Book), but unpredictable. Japanese encephalitis in a Danish short-term traveler to Cambodia. J Travel Med. 2011;18(6):411-3. - Fatal Japanese encephalitis in a Danish tourist visiting Bali for 12 days. Scand J Infect Dis. 1996;28(2):189.

Immunization of travelers against japanese encephalitis 6. Indications of vaccination among traveler French Health recommendations for travelers Stay (whatever duration) with outside exposure in an endemic region, particularly in rural areas ; Expatriation in a country located in a virus circulation area ; Any other situation estimated at risk by the medical practitionner.

Immunization of travelers against japanese encephalitis 7. Vaccines Table of JE Vaccines Appendix 4 - Background paper on japanese encephalitis vaccies Prepared by the SAGE Working Group on Japanese encephalitis vaccine October 1, 2014

Immunization of travelers against japanese encephalitis 7.2. Ixiaro® vaccine Classic schedule adults, children  2 months of age : 2 doses at day 0 and day 28 (1/2 dose < 3 years of age) ; - 1st booster 12 to 24 months after primary dose, before new exposure to JE virus (12 months in case of continuous exposure) ; 2nd booster adults 18-65 years of age : 10 years later (based on data of long term seroprotection). Accelerated schedule adults 18-65 years of age : 2 doses at day 0 and day 7.

Immunization of travelers against japanese encephalitis 7.3. Ixiaro® accelerated schedule Phase III study : 217 subjects 18-65 years old : 2 doses at day 0 and day7 + rabies vaccine ; 56 controls : classic schedule day 0-day 28. Seroconversion rate 7 and 28 days after 2nd injection : similar with both schedules. Seroconversion rate and antibody titers stayed high as long as 12 mois after 1st immunisation with both schedules. Jelinek T, Burchard GD, Dieckmann S, Buhler S, Paulke-Korinek M, Nothdurft HD, et al. Short-Term immunogenicity and safety of an accelerated preexposure prophylaxis regimen with Japanese encephalitis vaccine in combination with a rabies vaccine: a phase III, multicenter, observer-blind study. J Travel Med. 2015 Jul-Aug;22(4):225–31.

Immunization of travelers against japanese encephalitis 7.3. Accelerated schedule Not approved for other age categories : adults > 65 years of age, children < 18 years of age, since - no study on accelerated schedule ; - no data on long term seroprotection. It would be desirable however that last minute-travelers of these age categories may be immunized as well against Japanese encephalitis, when they are visiting endemic areas.

Thank you for your attention